UK Tumor Ablation Market Size & Outlook, 2023-2030
UK tumor ablation market, 2018-2030 (US$M)
Related Markets
UK tumor ablation market highlights
- The UK tumor ablation market generated a revenue of USD 85.7 million in 2023 and is expected to reach USD 201.2 million by 2030.
- The UK market is expected to grow at a CAGR of 13% from 2024 to 2030.
- In terms of segment, radiofrequency ablation was the largest revenue generating technology in 2023.
- Other Ablation Technologies is the most lucrative technology segment registering the fastest growth during the forecast period.
Tumor ablation market data book summary
| Market revenue in 2023 | USD 85.7 million |
| Market revenue in 2030 | USD 201.2 million |
| Growth rate | 13% (CAGR from 2023 to 2030) |
| Largest segment | Radiofrequency ablation |
| Fastest growing segment | Other Ablation Technologies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
Other key industry trends
- In terms of revenue, UK accounted for 5.1% of the global tumor ablation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany tumor ablation market is projected to lead the regional market in terms of revenue in 2030.
- Russia is the fastest growing regional market in Europe and is projected to reach USD 65.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tumor Ablation Market Scope
Tumor Ablation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK tumor ablation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.54% in 2023. Horizon Databook has segmented the UK tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
The UK tumor ablation market is anticipated to witness lucrative growth over the forecast period. High per capita income, presence of an established healthcare system, a significant number of healthcare professionals, proper access to healthcare services, availability of advanced devices, and favorable reimbursement policies are among the major factors driving the tumor ablation market in the UK.
Furthermore, presence of well-trained & skilled surgeons, technological advancements, favorable government initiatives, rising healthcare expenditure, and high adoption of minimally invasive surgeries are expected to contribute to market growth.
Furthermore, the UK market is expected to witness considerable growth over the forecast period due to the increasing geriatric population, growing prevalence of lifestyle diseases, and the presence of key players in the market.
Reasons to subscribe to UK tumor ablation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK tumor ablation market databook
-
Our clientele includes a mix of tumor ablation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into UK tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK tumor ablation market size, by technology, 2018-2030 (US$M)
UK Tumor Ablation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
